Immunomedics, Inc.

Patents = 410

Trademarks = 14

Forward Citations = 10,701

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

121 inventors (with patents filed for the assignee):

Immunomedics, Inc. is a biopharmaceutical company dedicated to developing innovative antibody-based therapies for the treatment of cancer. With a focus on antibody-drug conjugates (ADCs), Immunomedics aims to provide targeted and effective treatments that can improve outcomes for patients. Supported by a strong pipeline of product candidates, the company is committed to advancing the science of cancer therapeutics. Visit their website to learn more about Immunomedics and their groundbreaking research and developments in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com